EMEsti Mumpuni

Esti Mumpuni

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Esti Mumpuni has a total of 41 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Gel Formulations of Syzygium myrtifolium Extract and Nanoparticles: Sunscreen, Antioxidant, and Skin Permeation Activities

    by Kosasih Kosasih, Widiya Chourinisa, Esti Mumpuni

    Syzygium myrtifolium, commonly known as red shoot leaves, is rich in flavonoids with potent antioxidant and photoprotective activities, underscoring its potential as a natural source for sunscreen development. Gel formulations were prepared by incorporating both the leaf extract and its nanoparticle form, and their sun protection factor (SPF) and antioxidant activities were evaluated. Extracts were obtained via ethanol maceration and subsequently processed into nanoparticles. Both forms were formulated into gels and assessed for physicochemical properties, SPF, antioxidant capacity, and skin permeation. The extract-based gel exhibited superior SPF and antioxidant activity compared to the nanoparticle gel, indicating strong photoprotective potential. These findings highlight S. myrtifolium gel formulations as promising natural photoprotective agents, with extract-based gels emerging as effective sunscreens with antioxidant activity, supporting the development of safer and more sustainable approaches to skin photoprotection.

  • Open Access

    Molecular Docking Study of Bioactive Compounds in Senggugu (Clerodendrum serratum (L.) Moon) as Antidiabetics

    by Yahdi Thia Rhahmadini, Esti Mulatsari, Iqbal Ananda Taqwa, Muhammad Dhani, Agus Mawijaya, Evi Susanti, Josua Donrio Simanjuntak, Esti Mumpuni, Andri Prasetiyo

    Senggugu has the potential to be a source of natural medicine through its compounds. Using in silico approaches is an effective strategy for exploring compounds from natural products in the screening process. In vivo studies on senggugu have indicated that the plant has antidiabetic activity, although the active compounds involved in this activity are unknown. This study aims to explore the content of bioactive compounds of Senggugu (Clerodendrum serratum (L.) Moon) and its mechanism of action as an antidiabetic in silico with Molegro Virtual Docker software, ChemDraw, visualization with Discovery Studio, and ADMET prediction with pkCSM. The study was conducted by simulating the molecular docking of 31 bioactive compounds in Senggugu (Clerodendrum serratum (L.) Moon) with comparison compounds using glibenclamide, miglitol, rosiglitazone, linagliptin, and empagliflozin. The validated target proteins comprised 5 (five) receptors with PDB ID codes 4YVP, 5NN6, 7AWC, 6Y0F, and 7VSI. Based on this study, the compound predicted to be active as an antidiabetic is [(1S,2S,6R,7S,11R)-11-hydroxy-5,9,13-trimethylidene-4-oxo-3,14-dioxatricyclo [9.2.1.02,6] tetradecan-7-yl]2-methylprop-2-enoate at receptor 4YVP with a rerank score of -107.663 kcal/mol with glibenclamide -94.8299 kcal/mol and [3-hydroxy-4-[(2R)-6-methylhept-5-en-2yl]phenyl]methyl3-methylbut-2-enoate at 5NN6 receptor with a rerank score of -87.8719 with miglitol -64.7212 kcal/mol.


  • Open Access

    FACE MIST FORMULATION OF CHRYSANTHEMUM INDICUM L. FLOWER ETHANOLIC EXTRACT, ANTIOXIDANT ASSAY, AND IN SILICO TOXICITY PREDICTION

    by Yuslia Noviani, Agnes Hanandhieta, Esti Mumpuni

    Objective: Chrysanthemum indicum Linné (L.) flower is one of the popular ornamental plants in Indonesia. It is known to contain antioxidants that are essential for protecting our skin from free radicals. The objective of this study is to perform an in silico toxicity prediction of Chrysanthemum indicum L. metabolites, to formulate the Chrysanthemum indicum L. flower ethanolic extract into a face mist preparation, and to analyze the effect of extract variations on the physical and chemical stability and antioxidant activity of face mist preparations. Methods: The antioxidant activity was evaluated using the 2,2-diphenyl-1-picrylhydrazyl (DPPH) assay; toxicity prediction was performed with the pkCSM Website. The extract was formulated into face mist preparations with 0.4, 0.6, and 0.8% concentrations. Furthermore, the stability of the face mist preparations was assessed through the cycling test. Finally, the data results were analyzed using a two-way Analysis of Variance (ANOVA). Results: The majority of the metabolites derived from Chrysanthemum indicum L. were found to be non-toxic. All formulations of the face mist preparation were liquid, exhibiting a color range from yellowish-brown to dark yellowish-brown, and had a rose-like scent. The formulations met the requisite specifications of specific gravity, clarity, spray dispersibility, drying time, and pH. The IC50 values of face mist preparations were 87.75±0.02 ppm (F1), 77.57±0.02 ppm (F2), and 53.51±0.03 ppm (F3). After completing the cycling test, a rise in IC50 values was observed, with the values increasing to 88.28±0.04 ppm (F1), 79.74±0.009 ppm (F2), and 56.94±0.008 ppm (F3). Conclusion: The extract concentration variation significantly affected the face mist preparation's clarity, pH, and antioxidant stability.

  • Open Access

    IN SILICO INVESTIGATION OF SMALLANTHUS SONCHIFOLIUS COMPOUNDS AS DPP-4 INHIBITORS FOR ANTIDIABETIC MECHANISMS

    by Novi Yantih, Zuhelmi Aziz, Esti Mumpuni, Nurul Widayanti, Andri Prasetiyo

    Objective: Smallanthus sonchifolius has been scientifically demonstrated to possess antidiabetic activity through the inhibition of DPP-4 in in vitro studies. However, there is still a lack of comprehensive research identifying the specific bioactive compounds responsible for this effect. This research specifically aims to explore the potential of bioactive compounds from Smallanthussonchifoliusas DPP-4 inhibitors, a known target for antidiabetic treatment, using in silico techniques. Methods: The methodologies employed in this study includedmolecular docking, ADMET prediction, and molecular dynamics simulation. The docking process was conducted on 20 test compounds against native ligands within the receptor designated by code 3G0B, as well as against comparative compounds. Results: Molecular docking analysis revealed four compounds—3,4-dicaffeoylquinic acid, Nystose, 1,3-O-dicaffeoylquinic acid, and 3,5-caffeoylquinic acid-that exhibited lower rerank scores than the positive control, alogliptin. Further investigation through molecular dynamics simulations demonstrated that the Nystose-ligand complex displayed stable binding dynamics similar to alogliptin, maintaining consistent interactions throughout the simulation. Key amino acid residues, including Glu205, Glu206, Ser209, Tyr547, Tyr662, and Ser630, were involved in critical hydrogen bonding, contributing to the stability of the Nystose complex. However, despite its promising binding profile, Nystose is predicted to have limited intestinal absorption due to the high number of polar substituents, which may impact its bioavailability. Conclusion: Nystose is predicted to act as a DPP-4 inhibitor for diabetes treatment based on findings from molecular docking and molecular dynamics simulations.


  • Open Access

    Impact of Storage Duration and Container Materials on Hydroxy Methyl Furfural Levels in Indonesian Trigona Honey

    by Esti Mumpuni, Esti Mulatsari, Husna Kayla Isria

    Hydroxymethyl Furfural (HMF) is a six-carbon heterocyclic organic compound containing aldehyde and alcohol functional groups. It is formed from reducing sugars when heated through the Maillard reaction. HMF is widely recognized as an indicator of honey quality, reflecting the time and type of storage container used. In this study, we analyzed HMF content to investigate the effects of different storage container types and durations on HMF levels in honey. The analysis was conducted using High-Performance Liquid Chromatography (HPLC) with the following parameters: a mobile phase of acetonitrile:water in a 10:90 ratio, a stationary phase of octadecylsilane (C18), a flow rate of 1.0 mL/min, and a UV detector set to 280 nm. The results showed an increase in HMF content during the storage process, with variations depending on the container type and the storage duration. The highest HMF level recorded was 47.7931 μg/g in honey stored in transparent glass bottles for 8 months. These findings indicate that both the container type and the storage duration significantly influence HMF accumulation in honey, making it an important parameter for evaluating honey quality.

  • Open Access

    In silico discovery of potential sodium-glucose cotransporter-2 (SGLT-2) inhibitors from Smallanthus sonchifolius (Poepp.) H.Rob. via molecular docking and molecular dynamics simulation approach

    by Andri Prasetiyo, Esti Mumpuni, Dewi Luthfiana, Rina Herowati, Galih Satrio Putra

    Context: Smallanthus sonchifolius or yacon has been reported to have hypoglycemic effects. Inhibition of sodium-glucose cotransporter 2 (SGLT-2) is one of the mechanisms of antidiabetic drugs. Aims: To evaluate potential compounds in S. sonchifolius as SGLT-2 inhibitors using molecular docking analysis and dynamic simulation, as well as predict the pharmacokinetic profiles of the potent compounds using ADMETlab 3.0. Methods: Fourteen molecules from S. sonchifolius were docked with SGLT-2 (PDB Code 7VSI) simultaneously as empagliflozin and canagliflozin as standard ligands. Three compounds, they are 3,5-dicaffeoylquinic acid (3,5-DCQA); and 3,4-dicaffeoylquinic acid (3,4-DCQA), 1-kestose, showed lower rerank scores than empagliflozin and canagliflozin. The analysis proceeded to molecular dynamic simulation by investigating the RMSD and binding energy of SGLT-2 protein in complexes with the ligands to evaluate the dynamic behavior of protein-ligand complexes. Results: All ligands illustrate similar patterns with two ligand controls, suggesting its acceptable movement from the binding site of SGLT-2. 1-Kestose exhibited stronger binding affinity with SGLT-2 during the period of simulation and continued to interact with the binding pocket of SGLT-2 until the end of the simulation, which involved some critical residues, including Phe98, Glu99, and Ser287, and mainly contributed to hydrogen bond interactions. However, 1-kestose was predicted to have low gastrointestinal absorption due to many polar substituents, while 3,4-DCQA and 3,5-DCQA have higher gastrointestinal absorption. Conclusions: One phytochemical present in S. sonchifolius is 1-kestose, which is thought to have action as an SGLT-2 inhibitor for the treatment of diabetes based on the findings of molecular docking and molecular dynamics investigations. This compound falls into BCS Class III, which means it has good solubility but poor permeability.


  • Open Access

    In Silico Analysis of Bioactive Compounds in The Faloak (Sterculia quadrifida R. Br) Stem Bark to Identify Antidiabetic Activity

    by Fajar Dwi Utami, Rizqi Akbar Fandi Achmad Daud, Adi Nurmayati, Monika Buka Kopon Ratumakin, Chris Nicholas Siung, Adiva Stephanie, Almufti Fadillah, Esti Mulatsari, Esti Mumpuni, Andri Prasetyo

    Sterculia quadrifida R. Br or known as the faloak plant is a typical plant originating from the East Nusa Tenggara region, Indonesia. This plant has long been used by local people in the treatment of diabetes. In vivo, bioactive compounds from the extract of stem bark Sterculia quadrifida R. Br have been reported to have antidiabetic activity. The present study aims to analyse the potential of bioactive compounds in the faloak stem bark as inhibitors of the enzymes ?-glucosidase, PPAR-?, SGLT2, and DPP-IV. The preparation of bioactive compounds and their comparison was conducted utilising ChemDraw 2D & 3D, while proteins were obtained from the Protein Data Bank (PDB). The docking process used Molegro Virtual Docker, and visualisation was performed using BIOVIA Discovery Studio. Pharmacokinetic prediction (ADMET) was also carried out using the pkCSM website. The results of molecular docking with DPP-IV receptors showed that three bioactive compounds of faloak have better affinity than the comparative compounds, namely beta sisterol (-98.8838) to Alogliptin, Linagliptin, and Sitagliptin. While epicatechin (-83.9022) and cathecin (-83.4336) have better affinity than the comparative compounds Vidagliptin, Saxagliptin.

  • Open Access

    Analisis In Silico Senyawa Curcuma xanthorrhiza dan Moringa oleifera sebagai Kandidat Antiinflamasi

    by Lusi Nursilawati Syamsi, Syamsudin Syamsudin, Esti Mumpuni, Wahyu Widowati, Okta Nursanti, Rahmatul Qodriah

    Inflammation is the body's immune response to pathogens, tissue injury, or exposure to toxic substances. The search for effective anti-inflammatory agents remains a key focus in pharmaceutical and healthcare research. Temulawak (Curcuma xanthorrhiza) and Moringa (Moringa oleifera) have been widely used in traditional medicine due to their bioactive compounds with potential anti-inflammatory effects. This study aims to evaluate the molecular interactions between curcumin from temulawak, as well as quercetin and kaempferol from moringa, against inflammatory targets using an in silico approach through molecular docking and molecular dynamics simulations.


  • DIPEPTIDYL-PEPTIDASE-4 INHIBITORS FROM TINOSPORA CRISPA AS REVEALED BY METABOLOMICS STUDY, MOLECULAR DOCKING AND MOLECULAR DYNAMICS SIMULATION APPROACHES

    by Andri Prasetiyo, Shirly Kumala, Esti Mumpuni, Raymond R. Tjandrawinata, Nancy Dewi Yuliana

    Objective: This study aims to identify potential compounds as inhibitors of DPP-4 from Tinospora crispa. Material and Method: Tinospora crispa stem powder was extracted by ultrasonication. The DPP-4 inhibition test used the MAK 203 screening kit protocol. LC-MS/MS was used to determine the chemical profile. MetaboAnalyst5 and SIMCA were used to analyze the dataset. Molecular docking was performed using Molegro virtual docker, and molecular dynamics simulations were performed using YASARA dynamics employing the AMBER14 force field. Result and Discussion: The percentage inhibition of DPP-4 results showed that the most active was 96% ethanol extract. Orthogonal projection to latent structure (OPLS) analysis provides that 6'-O-LactoylBorapetoside B correlates most with DPP-4 inhibitory activity based on VIP value and Y coefficient. In the docking molecular analysis, 6’-O-LactoylBorapetoside B was predicted to be active as DPP-4 inhibitors with a lower rerank score (−106.51 Kcal/Mol) than alogliptin as a reference (−96.02 Kcal/mol). In molecular dynamics simulation for 100 ns, 6’-O-LactoylBorapetoside B complex of binding with DPP-4 protein was stable with the movement of the RMSD value below 3Å. 6'-O-Lactoyl Borapetoside B has a potential of being a DPP-4-inhibitor. But these results must be tested in vitro and in vivo in order to confirm its activity as a DPP-4 inhibitor.


  • Open Access

    Ultrasonic Assisted Synthesis of 1,5-Bis(3'-ethoxy-4'-hydroxyphenyl)-1,4-pentadiene-3-one: Effect of Time and Temperature

    by Esti Mulatsari, Esti Mumpuni, Agus Purwanggana, Sinta Rahmadani

    The compound 1,5-bis(3′-ethoxy-4′-hydroxyphenyl)-1,4-pentadiene-3-one (EHP), an analog of curcumin, displays significant antioxidant, anti-inflammatory and antibacterial properties. Synthesized through an aldol condensation reaction, EHP modifies the structure of curcumin by substituting methoxy groups with ethoxy groups and converting diketones to monoketone. This study explores the influence of time and temperature on the ultrasonic-assisted synthesis of 1,5-bis(3′-ethoxy-4′-hydroxyphenyl)-1,4-pentadiene-3-one (EHP). The synthesis process involved precise measurements and controlled conditions to achieve the desired compound. Through a series of experiments conducted at varying temperatures and irradiation times, the synthesis yield and purity of EHP were evaluated. Analysis techniques including thin layer chromatography (TLC), densitometry, ultraviolet-visible (UV-vis) spectrophotometry, Fourier-transform infrared spectroscopy (FTIR), liquid chromatography-mass spectrometry (LC-MS) and nuclear magnetic resonance (NMR) spectroscopy were employed to characterize the EHP compound. The results indicate the sensitivity of EHP synthesis to reaction conditions, it reduce synthesis time (10 min) with improve the product yield (87.17%) at moderate temperature (30 ºC). The findings provide valuable insights into optimizing synthesis conditions for enhanced product quality.